Uncategorized

A new regulation pending in front of the Office of Management and Budget suggests the Trump administration may be moving to overhaul the controversial financing mechanism.

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend timelines for robot purchases.

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.

  Estamos en un momento en el que estamos asistiendo a una especie de lucha abierta entre los defensores del dinero en efectivo y quienes promueven los pagos digitales. No seré yo quien quiera librarse de los billetes y monedas, pero hay que reconocer que los pagos virtuales facilitan …

Tom Langan will step down from his role on July 31, a little more than a year after he assumed the interim chief executive role. It’s another leadership shakeup for the health IT firm.

Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new targets for an undisclosed autoimmune disorder.

The deal is a blast from the not-too-distant past, when special purpose acquisition companies were an easy way for companies to list on the public market with a bundle of cash to operate on.

Explore how over 200 countries’ imports, exports and trade balances with the U.S. last year stack up in this sortable chart.

The so-called ‘Most Favored Nations’ rule would set drug pricing for Medicare in line with the prices paid by other nations, where drugs can be much cheaper.

Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.